RISATO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 176
AS - Asia 83
SA - Sud America 6
Totale 493
Nazione #
US - Stati Uniti d'America 228
IT - Italia 134
SG - Singapore 37
CN - Cina 33
FI - Finlandia 10
SE - Svezia 8
FR - Francia 6
GB - Regno Unito 6
TW - Taiwan 5
BR - Brasile 3
DE - Germania 3
NL - Olanda 3
CO - Colombia 2
GR - Grecia 2
ID - Indonesia 2
IN - India 2
PH - Filippine 2
TR - Turchia 2
AT - Austria 1
CL - Cile 1
IE - Irlanda 1
PT - Portogallo 1
UA - Ucraina 1
Totale 493
Città #
Chandler 33
Padova 33
Singapore 30
Fairfield 18
Ashburn 15
Milan 14
Boardman 13
Cambridge 13
Beijing 11
Seattle 10
Houston 9
Helsinki 8
Santa Clara 8
Wilmington 8
Chiampo 7
Vicenza 6
Woodbridge 6
Meda 5
Medford 5
Princeton 5
Venice 5
Cagliari 4
Des Moines 4
Amsterdam 3
Banqiao 3
Campo San Martino 3
Hummelstown 3
Pordenone 3
Rome 3
Verona 3
Vila Velha 3
Ankara 2
Ann Arbor 2
Bogotá 2
Bologna 2
Brendola 2
Lappeenranta 2
Malang 2
Manila 2
New York 2
Poplar 2
Portland 2
Rhodes 2
Roxbury 2
San Diego 2
Sorga 2
Taipei 2
Trento 2
Turate 2
Acton 1
Arzignano 1
Atlanta 1
Belluno 1
Bhubaneswar 1
Brescia 1
Bristol 1
Cassino 1
Cento 1
Columbus 1
Concepción 1
Daverio 1
Dongguan 1
Dosolo 1
Dublin 1
Forest Park 1
Frankfurt am Main 1
Greenville 1
Kharkiv 1
London 1
Mulazzano 1
New Bedfont 1
Paris 1
Parma 1
Pescara 1
Pune 1
Raleigh 1
Vienna 1
Totale 358
Nome #
Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery 84
Use of Zebrafish models for studying Arrhythmogenic Cardiomyopathy 81
Efficient clofilium tosylate-mediated rescue of POLG-related disease phenotypes in zebrafish 64
Hyperactivation of Wnt/β-catenin and Jak/Stat3 pathways in human and zebrafish foetal growth restriction models: Implications for pharmacological rescue 43
Zebrafish as a model for sarcoglycanopathies: in-depth analysis of the disease phenotype 41
Novel animal models for sarcoglycanopathy 37
Novel zebrafish models for sarcoglycanopathy 34
Wnt/ Beta-catenin signaling reduction as a therapeutically targetable mechanism in different zebrafish models for Arrhythmogenic Cardiomyopathy. 34
Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatment 25
A novel DSP zebrafish model reveals training- and drug-induced modulation of arrhythmogenic cardiomyopathy phenotypes 23
Small molecules to rescue folding-defective sarcoglycans: in vivo assessment of novel therapeutic strategies 21
Modeling Sarcoglycanopathy in Danio rerio 17
In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models 6
Totale 510
Categoria #
all - tutte 2.759
article - articoli 2.091
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 0 0 8 5 4 0
2020/202141 4 0 7 0 0 0 14 2 7 4 1 2
2021/202259 2 6 7 4 6 5 4 3 3 0 5 14
2022/2023100 7 10 8 8 14 11 0 11 13 3 12 3
2023/2024164 7 16 27 18 19 18 11 16 2 3 17 10
2024/2025129 10 46 25 29 19 0 0 0 0 0 0 0
Totale 510